Objective To compare the performance of screening for pre-eclampsia (PE) based on risk factors from medical history, as recommended by NICE and ACOG, with the method proposed by The Fetal Medicine Foundation (FMF)

CondensationProphylactic use of aspirin in women at high-risk of preeclampsia reduces substantially the length of stay in the neonatal intensive care unit. Short version of article title Secondary analysis of ASPRE trial Implications and ContributionsA. The study was conducted in women at high-risk of preeclampsia to examine the effect of prophylactic use of aspirin during pregnancy on length of stay in the neonatal intensive care unit. B. Prophylactic use of aspirin reduces the length of stay in neonatal intensive careunit by about 70%, mainly due to a decrease in the rate of births at <32 weeks' gestation because of prevention of early-preeclampsia.C. In women at high-risk of preeclampsia prophylactic use of aspirin reduces substantially both the risk of preterm-preeclampsia and length of stay in neonatal intensive care unit. M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 3 ABSTRACTBackground: Preeclampsia is a major pregnancy complication with adverse short-